Lou was the Editor-in-Chief of the Nanomedicine: Nanotechnology, Biology, and Medicine (Elsevier) journal from 2008 until 2016. He scaled NNBM from an being upstart scientific journal to a solid journal with a 2014 IF of 6.15, (5 Year IF=7.51). Dr. Balogh is an accomplished senior scientist and leader, with interdisciplinary background and business experience in chemistry, bioengineering, nanotechnology, nanomedicine, and drug delivery both in laboratory and industrial settings. Lou is the Principal of AA Nanomedicine & Nanotechnology Consulting that provides expert advice in nanomedicine and assesses technical feasibility of projects in Nanotechnology and Nanomedicine for private investors, scientific institutes, and government agencies since 2000.
Nanomedicine, Biomedical Engineering, Chemistry, Materials Science, and Pharmacology